Open access
102
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Cost-Effectiveness Analysis of Gefitinib Alone and Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Small-Cell Lung Cancer
Yao Wang1 School of Pharmacy, Anhui Medical University, Hefei, 230032, People’s Republic of China;2 Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, People’s Republic of China
, Kaiyu Huang1 School of Pharmacy, Anhui Medical University, Hefei, 230032, People’s Republic of China;2 Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, People’s Republic of China
, Sijia Sun1 School of Pharmacy, Anhui Medical University, Hefei, 230032, People’s Republic of China;2 Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, People’s Republic of China
, Yahong Deng1 School of Pharmacy, Anhui Medical University, Hefei, 230032, People’s Republic of China;3 Department of Pharmacy, First Affiliated Hospital of Anhui Medical University, Hefei, 230000, Anhui, People’s Republic of China
& Xuefeng Xie1 School of Pharmacy, Anhui Medical University, Hefei, 230032, People’s Republic of China;2 Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, People’s Republic of ChinaCorrespondence[email protected]
Pages 351-359
|
Published online: 01 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.